Publicaciones Científicas
Lessons learnt from PETHEMA’s RWD research: A clinical perspective
Alfonso J. Santiago-Marí, Irene Salcedo-Marín, Roberto Maldonado, Carmen López-Carrero, David Martínez-Cuadrón, Pau Montesinos
Long-term benefits of autologous stem cell transplantation versus intensive chemotherapy consolidation for acute myeloid leukemia patients: A propensity score matching analysis from the PETHEMA AML registry
Ana Alfonso-Pierola, David Martinez-Cuadrón, Rebeca Rodríguez-Veiga, Cristina Gil, Pilar Martínez-Sánchez, Teresa Bernal, Celina Benavente, Mónica A. Romero-Riquelme, Josefina Serrano-Lopez, Juan M…
Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry.
Jorge Labrador; David Martínez-Cuadrón; Blanca Boluda; Josefina Serrano; Cristina Gil; José A Pérez-Simón; Teresa Bernal; Juan M Bergua; Joaquín Martínez-López; Carlos Rodríguez-Medina; María B…
Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia.
Esperanza Martín-Sánchez; Laura Blanco; Peter S Kim; Kamlesh Bisht; Hongfang Wang; Helgi Van de Velde; Tomas Jelinek; Catia Simoes; Felipe Prosper; Jesus F San Miguel; Ana Alfonso; Juan Bergua;…
Expression profile of Bcl-2 family proteins in newly diagnosed multiple myeloma patients.
Cristina De Ramón; Elizabeta A Rojas; Irena Misiewicz-Krzeminska; Ignacio J Cardona-Benavides; Myriam Cuadrado; Isabel Isidro; María-José Calasanz; Manuela Fernandez; Ramón García-Sanz; Noemi Puig; M…
Preferential Genetic Pathways Lead to Relapses in Adult B-Cell Acute Lymphoblastic Leukemia.
Josgrey Navas-Acosta; Alberto Hernández-Sánchez; Teresa González; Ángela Villaverde Ramiro; Sandra Santos; Cristina Miguel; Jordi Ribera; Isabel Granada; Mireia Morgades; Ricardo Sánchez; Esperanza…
Single-point and kinetics of peripheral residual disease by mass spectrometry to predict outcome in patients with high-risk smoldering multiple myeloma included in the GEM-CESAR trial.
Noemí Puig; Cristina Agulló; Teresa Contreras; José-Juan Pérez; Irene Aires; María-José Calasanz; Ramón García-Sanz; Sergio Castro; Joaquín Martínez-López; Paula Rodríguez-Otero; Verónica González…
Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA Groups.
Susana Vives; David Quintela; Mireia Morgades; Isabel Cano-Ferri; Alfons Serrano; Evelyn Acuña-Cruz; Marta Cervera; Marina Díaz-Beyá; Belén Vidriales; José Ángel Raposo-Puglia; Montserrat Arnan; Ana…
Immunotherapy in first line treatment of adult acute lymphoblastic leukemia.
Anna Torrent; Josep-Maria Ribera
Inotuzumab ozogamicin in adult acute lymphoblastic leukemia: Development, current status, and future directions.
Hagop M Kantarjian; Nicolas Boissel; Cristina Papayannidis; Marlise R Luskin; Matthias Stelljes; Anjali S Advani; Elias J Jabbour; Josep-Maria Ribera; David I Marks